The short answer
Estring is a flexible vaginal ring that releases a low dose of estradiol continuously for 90 days. Its current label approves it for moderate-to-severe symptoms of vulvar and vaginal atrophy due to menopause. Estring was one of the first six hormone therapy products whose labels the FDA revised in February 2026, and its current label no longer has a boxed warning. It is different from Femring, a higher-dose systemic ring.
Safety on the current Estring label
Estring's current label (DailyMed, April 2026) no longer has a boxed warning; it was among the first six labels the FDA revised on February 12, 2026. Warnings and precautions still apply.
Label contraindications: abnormal genital bleeding of unknown cause, known or suspected estrogen-dependent cancer, current or past blood clots, current or past stroke or heart attack, serious allergy to the product, liver disease, and known clotting disorders such as protein C, protein S, or antithrombin deficiency. Any bleeding after menopause should be evaluated.
Current label check
The medication-specific claims on this page were checked against these current product labels on 2026-10-03.
| Product label | Label date | Boxed warning on that label |
|---|---|---|
| Estring (estradiol vaginal system) | 2026-04-23 | None (revised label) |
Established evidence
FDA-approved use
Treatment of moderate-to-severe symptoms of vulvar and vaginal atrophy due to menopause, such as dryness, burning, irritation, and painful sex.
How it is used
The label directs inserting the ring as deeply as possible into the upper third of the vagina, where it stays continuously for three months and is then replaced. If it slips out, it can be rinsed in lukewarm water and reinserted. Many people cannot feel it once placed.
Estring vs other vaginal estrogen
| Product | Form | Boxed warning on current label |
|---|---|---|
| Estring | Ring, every 90 days | None (revised) |
| Vagifem / Yuvafem | Insert, twice weekly after start-up | Yes (older wording) |
| Imvexxy | Softgel insert | Yes (older wording) |
| Estrace vaginal cream | Cream | Yes (older wording) |
Established evidence
What the evidence shows
Randomized trials show low-dose vaginal estrogen improves dryness, pH, and painful sex. The Menopause Society considers low-dose vaginal estrogen first-line prescription therapy for genitourinary syndrome of menopause and says a progestogen is generally not needed.
Established evidence
Common side effects
- Vaginal discharge or discomfort
- Vaginal irritation
- Ring slipping out
- Spotting, which should be reported
Questions to ask a healthcare professional
- Is a ring easier for me than inserts or cream?
- Is Estring appropriate with my cancer history?
- What if the ring keeps slipping?
Questions, answered
What people ask about Estring
Does Estring treat hot flashes?+
No. It delivers a low local dose for vaginal symptoms. Femring is a different, systemic ring.
Does Estring still have a boxed warning?+
No. Its revised label, approved in February 2026, no longer has a boxed warning.
Does Kindr Health offer Estring?+
This page is educational and does not state or imply availability through Kindr Health.
Kindr Health does not claim to offer Estring on this page. Availability and prescribing are not implied.
A broader care pathway
Explore menopause care
Learn how Kindr Health care pathways work. An educational page is not a statement that this medication is available or appropriate for you.
SOURCES & REFERENCES
Every clinical claim on this page is sourced.
- Estring (estradiol vaginal system) prescribing information (2026) — DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=110b9865-5a07-4d45-b560-e89947f12600
- FDA approves labeling changes to menopausal hormone therapy products (first six labels) (2026) — U.S. Food and Drug Administration. www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
- The 2020 genitourinary syndrome of menopause position statement (2020) — The Menopause Society (Menopause journal). pubmed.ncbi.nlm.nih.gov/32852449
This resource is educational and does not replace individualized medical advice. Do not start, stop, or change a prescription without guidance from a licensed healthcare professional.